NasdaqGS - Delayed Quote USD
Metsera, Inc. (MTSR)
28.12
+1.40
+(5.24%)
At close: 4:00:01 PM EDT
29.04
+0.92
+(3.27%)
After hours: 5:20:10 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 3 |
| Avg. Estimate | -0.61 | -0.76 | -3.19 | -3.21 |
| Low Estimate | -0.61 | -0.76 | -3.19 | -3.4 |
| High Estimate | -0.61 | -0.76 | -3.19 | -3.09 |
| Year Ago EPS | -- | -- | -14.49 | -3.19 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2024 | 3/31/2025 |
|---|---|---|
| EPS Est. | -0.8 | -1.04 |
| EPS Actual | -3.52 | -1.03 |
| Difference | -2.72 | 0.01 |
| Surprise % | -340.00% | 0.96% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.61 | -0.76 | -3.19 | -3.21 |
| 7 Days Ago | -0.64 | -0.75 | -2.18 | -3.14 |
| 30 Days Ago | -0.6 | -0.8 | -2.69 | -3.14 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | 1 | -- | -- | 1 |
| Down Last 30 Days | 1 | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MTSR | -- | -- | 77.98% | -0.73% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Initiated | Guggenheim: Buy | 2/25/2025 |
| Initiated | Cantor Fitzgerald: Overweight | 2/25/2025 |
| Initiated | Evercore ISI Group: Outperform | 2/25/2025 |
| Initiated | B of A Securities: Buy | 2/25/2025 |
Related Tickers
MAZE Maze Therapeutics, Inc.
12.10
+20.88%
GPCR Structure Therapeutics Inc.
21.79
+0.14%
AARD Aardvark Therapeutics, Inc.
11.13
+6.61%
SION Sionna Therapeutics, Inc.
13.97
+2.05%
CYTK Cytokinetics, Incorporated
31.21
+0.61%
IMVT Immunovant, Inc.
15.41
+3.77%
APGE Apogee Therapeutics, Inc.
36.33
-0.85%
LXEO Lexeo Therapeutics, Inc.
2.7200
0.00%
ASND Ascendis Pharma A/S
175.69
+7.89%
SRRK Scholar Rock Holding Corporation
29.76
+2.59%